Allotrope Medical, a medical device company whose FDA cleared product StimSite™ helps surgeons locate and identify ureters during pelvic surgery, announced the completion of an oversubscribed $4 million Series A financing. This round was led by Rockies Venture Club (RVC), with participation from notable investment groups including Aggie Angel Network, Bellingham Angels, Berkeley Angel Network, Kentucky Select Fund, MEDA Angels, Prosalus Capital, Seedfolio, Tech Coast Angels (Orange County and San Diego), and Texas Halo Fund among both existing and new investors.

Allotrope Medical is a commercial stage medical device company that has developed StimSite™ - a FDA cleared smooth muscle stimulation device that leverages the surgeon's existing laparoscopic and robotic instruments to rapidly and safely help identify and locate the ureter during pelvic operations. StimSite™ connects with on-market surgical instruments with no modification to ensure seamless workflow integration and ease of universal connectivity and installation in any operating room in minutes.